Cytokinetics
Kenna Reehil is a seasoned marketing professional with extensive experience in the healthcare and pharmaceutical industries. Currently serving as Senior Director and Global Marketing Lead for omecamtiv mecarbil at Cytokinetics since December 2017, Kenna Reehil focuses on the commercialization strategy for a late-stage clinical asset in heart failure. Previous roles include Independent Consultant and Heart Diseases Team Leader for Global Marketing at Pfizer, where Kenna Reehil developed a global digital marketing platform and led cross-functional teams. A background in market analytics covers multiple therapeutic areas, and earlier experience involves strategic consulting for healthcare clients at The Wilkerson Group and Vector Research, Inc. Kenna Reehil holds a BA in Psychology and a Master of Public Health with a focus on Health Policy and Administration from the University of Michigan.
Cytokinetics
15 followers
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.